| Financial Year |
March 31 2023 |
| Monetary Funds |
242,639,314.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,609,032.82 |
| Accounts Receivable |
938,397,728.42 |
| Advances to Suppliers |
4,589,440.35 |
| Other Receivables |
55,918,833.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,937,878.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
912,235.15 |
| Other Current Assets |
4,398,802.04 |
| Total Current Assets |
3,354,750,536.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
9,506,896.40 |
| Long-term Equity Investment |
-- |
| Investment Properties |
214,367,173.22 |
| Fixed Assetes |
633,187,140.47 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,572,838.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
90,631,586.69 |
| Deferred Income Tax Assets |
54,868,024.13 |
| Other Non-Current Assets |
125,078,204.09 |
| Sub-Total of Non-Current Assets |
1,208,974,957.28 |
| Total Assets |
4,563,725,493.82 |
| Short-Term Loans |
1,036,483,947.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,000,000.00 |
| Accounts Payable |
2,179,406,996.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,030,584.39 |
| Taxes Payable |
17,160,994.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
71,629,140.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,969,630.94 |
| Other Current Liabilities |
207,698,234.61 |
| Sub-Total of Current Liabilities |
3,590,500,529.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,397,786.41 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
77,255,993.87 |
| Total Liabilities |
3,667,756,523.70 |
| Paid-In Capital(Or Share Stock) |
377,494,000.00 |
| Capital Surplus |
1,223,232,784.11 |
| Surplus Reserve |
99,544,068.22 |
| LESS:Treasury Stock |
10,710,000.00 |
| Undistributed Profits |
-1,102,109,833.74 |
| Minority Stockholder's Interest |
274,178,466.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
621,790,503.99 |
| Owner's Equity（Stockholder's Equity） |
895,968,970.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,563,725,493.82 |
